Traditional Chinese medicine extract for treating stagnation of blood stasis as well as preparation and preparation method thereof

Abstract

The invention relates to traditional Chinese medicine extract for treating stagnation of blood stasis as well as a preparation and a preparation method thereof. The traditional Chinese medicine extract is prepared by extracting 20 material medicines including red flowers, roots of common peony, ligusticum wallichii and the like. The traditional Chinese medicine extract has a very high curative effect for heart and cerebral vusculer diseases including cerebral infarction, coronary heart diseases and the like which are caused by stagnation of blood stasis, a small side effect and does not apply virulent animal medicines; a solid preparation prepared from the traditional Chinese medicine extract and auxiliary materials is preferably a pill or a tablet which has good stability, formability and effectiveness.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a traditional Chinese medicine extract for treating blood stasis and internal resistance, as well as its preparation and preparation method. Background technique [0002] In recent years, the incidence of cardiovascular and cerebrovascular diseases such as cerebral infarction and coronary heart disease has been increasing year by year, and it is showing a younger trend. Traditional Chinese medicine believes that it belongs to the category of "chest pain", "heartache" and "stroke". Both of these diseases are caused by internal resistance of blood stasis, mostly caused by dysfunction of viscera, or deficiency of qi and blood, combined with fatigue and internal injury, worry, anger, excessive drinking and eating, resulting in stagnation of blood stasis, phlegm and heat in the body. Accumulation, or yang transformation and wind movement, blood does not follow th...

AI Technical Summary

Problems solved by technology

[0003] In the prior art, Chinese patent medicines are mostly used for the treatment of cardiovascular and cerebrovascular diseases. For example, CN1334121 discloses a Tongxinluo pharmaceutical composition, which includes Codonopsis Radix, Radix Pseudostellariae, Radix Astragali, Atractylodes Rhizoma Atractylodes Rhizome and Radix Glycyrrhizae. One or more; one or more of 56 herbs such as leech, salvia, Chuanxiong, safflower, red peony, jiangxiang, notoginseng, turmeric, peach kernel, etc., and one of scorpion, cicada slough, and centipede One or more combination preparations, including the highly toxic animal medicines scorpion, cicada slough or centipede that play an irreplaceable role in the combination preparation; CN1457831 discloses a kind of medicine for treating cardiovascular and cerebrovascular diseases, and the raw material drug is composed of It is made of 55 raw materials such as safflower, Sichuan Achyranthes bidentata, papaya, astragalus, turmeric, licorice, and ginseng; , Ophiopogon japonicus, and honey-roasted licorice. The above traditional Chinese medicine compositions are all directly used as raw materials without treatment of the raw materials. As a result, the purity of the active ingredients in the composition is not high, and the single dose is large. , technical problems such as large side effects

Images